...
首页> 外文期刊>Virulence. >Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: Phylogenetic groups, virulence factors and biofilm formation
【24h】

Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: Phylogenetic groups, virulence factors and biofilm formation

机译:引起尿路感染持续或复发的大肠杆菌的特征:系统发育基团,毒力因子和生物膜形成

获取原文

摘要

Recurrent urinary tract infections (RUTIs) pose a major problem but little is known about characteristics of Escherichia coli associated with RUTI. This study includes E. coli from 155 women with community-acquired lower urinary tract infections (UTIs) randomized to one of three dosing regiments of pivmecillinam and aimed to identify associations between the presence of 29 virulence factor genes (VFGs), phylogenetic groups and biofilm formation and the course of infection during follow-up visits at 8-10 and 35-49 days post-inclusion, respectively.E. coli causing persistence or relapse were more often of phylogenetic group B2 and had a significantly higher aggregate VFG score than E. coli that were not detectable at follow-up. Specifically, these E. coli causing persistence or relapse were characterized by a higher prevalence of hemolysis and 12 VFGs (sfa/focDE, papAH, agn43, chuA, fyuA, iroN, kpsM II, kpsM II K2, cnf1, hlyD, malX and usp). KpsM II K2 and agn43aCFT073 were independently associated with persistence or relapse. No specific combination of presence/absence of VFGs could serve as a marker to predict RUTI. Stratifying for VFGs, seven days of pivmecillinam treatment reduced the prevalence of persistence or relapse of UTI compared with three days.In vitro biofilm formation was not higher among E. coli causing persistence or relapse. The presence of agn43aCFT073 or agn43bCFT073 was associated with biofilm forming capacity.In conclusion, our results show potential targets for prevention and treatment of persistence/relapse of UTI and potential markers for selecting treatment lengths and warrant studies of these and new VFGs.
机译:复发性尿路感染(RUTI)构成一个主要问题,但对与RUTI相关的大肠杆菌的特征知之甚少。这项研究包括来自155名社区获得性下尿路感染(UTI)的妇女的大肠杆菌,该妇女随机分配到pivmecillinam的三个给药方案之一,旨在确定29种毒力因子基因(VFGs),系统发生群和生物膜之间的关联。入组后分别在8-10天和35-49天进行随访时的感染形成和感染过程。引起持续性或复发的大肠癌更常见于系统发生组B2,并且其总VFG评分明显高于在随访中无法检测到的大肠埃希菌。具体而言,这些引起持久性或复发的大肠杆菌的特征是溶血和12种VFG的发生率较高(sfa / focDE,papAH,agn43,chuA,fyuA,iroN,kpsM II,kpsM II K2,cnf1,hlyD,malX和usp )。 KpsM II K2和agn43a CFT073 与持续性或复发独立相关。 VFG存在与否的特定组合不能用作预测RUTI的标记。对VFGs进行分层处理,吡维西南治疗7天可降低UTI持续性或复发的发生率,而三天可降低UTI持续性或复发的发生率。在大肠杆菌中,引起持久性或复发的体外生物膜形成并不高。 agn43a CFT073 或agn43b CFT073 的存在与生物膜形成能力有关。总之,我们的结果显示了预防和治疗UTI持续/复发的潜在靶标和潜在标志物选择治疗时长,并对这些和新的VFG进行研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号